Early vs Standard Delivery for Gastroschisis
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial examines the optimal timing for delivering babies with gastroschisis, a condition where a baby is born with intestines outside the body. It compares delivery at 35 weeks (early delivery) to waiting until 38 weeks (standard delivery) to determine which option results in better health outcomes for the baby, such as fewer breathing problems or reduced need for IV nutrition. The trial is open to mothers who are at least 18 years old, speak English or Spanish, have a single pregnancy, and have a confirmed diagnosis of gastroschisis in their baby by 33 weeks. As an unphased trial, this study provides a unique opportunity to contribute to important research that could improve delivery timing for babies with gastroschisis.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. Please consult with the study team or your healthcare provider for guidance.
What prior data suggests that early delivery for gastroschisis is safe?
Research has shown that delivering babies with gastroschisis at 35 weeks might reduce the risk of stillbirth and lower death rates. However, this approach could also lead to more health issues for the baby, such as breathing problems or the need for extra nutrition. The evidence on whether early delivery is better or worse remains unclear. Some studies have shown mixed results when comparing early delivery to waiting until later in pregnancy. Prospective participants should carefully consider these factors when deciding about joining a trial for early delivery in gastroschisis cases.12345
Why are researchers excited about this trial?
Researchers are excited about this trial because it could redefine the timing of delivery for babies with gastroschisis. Unlike the standard practice of waiting until around 38 weeks for delivery, this trial explores the potential benefits of delivering at 35 weeks. The primary goal is to determine if earlier delivery can reduce complications for these newborns, offering a potentially safer and more effective approach to managing gastroschisis. By pinpointing the optimal delivery time, this research could lead to better outcomes and improved health for both mothers and their babies.
What evidence suggests that this trial's treatments could be effective for gastroschisis?
This trial will compare early delivery at 35 weeks with standard delivery at 38 weeks for babies with gastroschisis. Research has suggested that delivering a baby with gastroschisis at 35 weeks might reduce the risk of stillbirths and deaths in the first year compared to waiting until 38 weeks. Some studies indicate that earlier delivery could decrease the chances of serious problems, such as breathing difficulties and the need for intravenous feeding after birth. However, results are mixed, and further research is needed to confirm these benefits. Nonetheless, earlier delivery appears to have some positive effects on the baby's health.12456
Who Is on the Research Team?
Amy Wagner, MD
Principal Investigator
Medical College of Wisconsin
Are You a Good Fit for This Trial?
This trial is for pregnant women over 18 with a single baby diagnosed with gastroschisis via sonogram by 33 weeks. They must have started prenatal care before 24 weeks, speak English or Spanish, and be able to consent. Excluded are those with certain health issues like preterm delivery history, severe diabetes, hypertension, or unstable pregnancies.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Randomization
Participants are randomized at 33 weeks to either delivery at 35 weeks or observation with a goal of delivery at 38 weeks
Delivery and Initial Neonatal Care
Participants are delivered at either 35 weeks or 38 weeks, followed by initial neonatal care and monitoring
Follow-up
Participants are monitored for safety and effectiveness after delivery until NICU discharge
What Are the Treatments Tested in This Trial?
Interventions
- 35-week delivery
- 38-week delivery
35-week delivery is already approved in United States for the following indications:
- Gastroschisis
Find a Clinic Near You
Who Is Running the Clinical Trial?
Medical College of Wisconsin
Lead Sponsor